Effect of Serum CEA on Antibody Clearance in Pancreatic Tumors
Author Information
Author(s): R.B. Pedley, J.A. Boden, R.W. Boden, A. Green, G.M. Boxer, K.p. Bagshawe
Primary Institution: Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross Hospital
Hypothesis
What is the relationship between serum CEA levels, tumor CEA levels, and tumor histology in a pancreatic tumor xenograft model?
Conclusion
Higher serum CEA levels lead to rapid clearance of antibody complexes, reducing tumor localization compared to lower serum CEA levels.
Supporting Evidence
- There was a strong correlation between tumor size and serum CEA levels in the high CEA group.
- Blood activity was reduced to 20% of the injected dose by 15 minutes in high CEA mice.
- Gamma-camera imaging confirmed the differences in antibody localization between high and low CEA groups.
Takeaway
This study shows that when there is a lot of a certain protein in the blood, it can make it harder for treatments to find and stick to tumors.
Methodology
The study used a pancreatic adenocarcinoma xenograft model in mice to measure serum and tumor CEA levels and the clearance of anti-CEA antibodies.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Female athymic (nu/nu) mice were used in the study.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website